Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fields.

Saved in:
Bibliographic Details
Title: Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fields.
Authors: Jimenez H; Department of Oncology, Wayne State University School of Medicine/Karmanos Cancer Institute, Detroit, MI 48201, USA., Gibo D; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA., Sharma S; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA., Pennison M; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA., Miller LD; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA., Wang M; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA., Sheffield K; Department of Oncology, Wayne State University School of Medicine/Karmanos Cancer Institute, Detroit, MI 48201, USA., Zhang L; Department of Oncology, Wayne State University School of Medicine/Karmanos Cancer Institute, Detroit, MI 48201, USA., Johansen A; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA., Achari P; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA., Mcgrath C; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA., Lester S; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA., Tang J; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA., Agyemang K; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA., Johnson A; Medical College of Georgia at Augusta University, Augusta, GA 30912, USA., Whitlow CT; Department of Radiology, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC 27103, USA., Chan M; Department of Radiation Oncology, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC 27103, USA., Watabe K; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA., D'Agostino R Jr; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA., Liyanage J; Department of Oncology, Wayne State University School of Medicine/Karmanos Cancer Institute, Detroit, MI 48201, USA., Azmi A; Department of Oncology, Wayne State University School of Medicine/Karmanos Cancer Institute, Detroit, MI 48201, USA., Barger G; Department of Neurology, Wayne State University, Detroit, MI 48202, USA., Barbault A; TheraBionic GmbH, Ettlingen, Germany., Lesser GJ; Department of Internal Medicine, Section on Hematology/Oncology, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC 27157, USA., Debinski W; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA., Pasche BC; Department of Oncology, Wayne State University School of Medicine/Karmanos Cancer Institute, Detroit, MI 48201, USA.
Source: Oncotarget [Oncotarget] 2025 Oct 13; Vol. 16, pp. 741-757. Date of Electronic Publication: 2025 Oct 13.
Publication Type: Journal Article; Case Reports; Research Support, N.I.H., Extramural
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Electronic Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1949-2553
DOI:10.18632/oncotarget.28770